- Home
- WAT vs HOLX Comparison
WAT vs HOLX Comparison
Compare WAT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAT
- HOLX
- Stock Information
- Founded
- WAT 1958
- HOLX 1985
- Country
- WAT United States
- HOLX United States
- Employees
- WAT N/A
- HOLX N/A
- Industry
- WAT Biotechnology: Laboratory Analytical Instruments
- HOLX Medical Electronics
- Sector
- WAT Industrials
- HOLX Health Care
- Exchange
- WAT Nasdaq
- HOLX Nasdaq
- Market Cap
- WAT 22.5B
- HOLX 18.3B
- IPO Year
- WAT 1995
- HOLX 1990
- Fundamental
- Price
- WAT $360.36
- HOLX $71.47
- Analyst Decision
- WAT Hold
- HOLX Buy
- Analyst Count
- WAT 12
- HOLX 13
- Target Price
- WAT $374.75
- HOLX $89.50
- AVG Volume (30 Days)
- WAT 514.6K
- HOLX 2.1M
- Earning Date
- WAT 02-04-2025
- HOLX 01-30-2025
- Dividend Yield
- WAT N/A
- HOLX N/A
- EPS Growth
- WAT N/A
- HOLX 81.42
- EPS
- WAT 10.48
- HOLX 3.32
- Revenue
- WAT $2,905,147,000.00
- HOLX $4,030,300,000.00
- Revenue This Year
- WAT $0.53
- HOLX $1.73
- Revenue Next Year
- WAT $5.59
- HOLX $4.07
- P/E Ratio
- WAT $34.40
- HOLX $21.68
- Revenue Growth
- WAT N/A
- HOLX N/A
- 52 Week Low
- WAT $279.24
- HOLX $70.24
- 52 Week High
- WAT $397.02
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- WAT 39.23
- HOLX 25.18
- Support Level
- WAT $380.60
- HOLX $74.71
- Resistance Level
- WAT $379.00
- HOLX $74.02
- Average True Range (ATR)
- WAT 9.35
- HOLX 1.81
- MACD
- WAT -3.33
- HOLX -0.52
- Stochastic Oscillator
- WAT 0.95
- HOLX 0.45
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.